Patent Yard Sign in
Canadian application, no grantCanada

Compositions and methods for isolation, propagation, and differentiation of human stem cells and uses thereof

CA 2463930 A1 · Owner: Celmed Biosciences, Inc. · Inventors: Levesque, Michel; Neuman, Toomas

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention is directed to the field of human stem cells and includes methods and compositions for isolating propagating, and differentiating human stem cells. The invention provides therapeutic uses of the methods and compositions, including autologous transplantation of treated cells into humans for treatment of Parkinson's and other neuronal disorders.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed August 8, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 8, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 8, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 8, 2002
GrantedNo grant recorded
Term endedAugust 8, 2022
Patent numberCA 2463930 A1
Classification (IPC)C12N5/00 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedAug 8, 2002Term endedAug 8, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.